Skip to main content
Top
Published in: Current Pediatrics Reports 4/2023

01-12-2023

Acute Liver Failure in Neonates and Early Infancy: an Approach to Diagnosis and Management

Authors: Sanu Raja Yadav, Praveen Kumar Conjeevaram Selvakumar, Kadakkal Radhakrishnan

Published in: Current Pediatrics Reports | Issue 4/2023

Login to get access

Abstract

Purpose of Review

Acute liver failure in neonates and early infancy is an uncommon condition with varied etiology and high mortality rates. We attempt to review the recent updates on the various causes, diagnostic approach, and specific management of acute liver failure in this unique population.

Recent Findings

Better diagnostic tools including genetic/molecular techniques have expanded our understanding of etiopathogenesis of neonatal/early infantile liver failure. Multidisciplinary team-led care and rapid arrival to diagnosis can lead to better outcomes.

Summary

Neonatal/early infantile acute liver failure is a devastating condition with rapid progressive hepatocellular injury and poor prognosis compared to older children. Most common etiology includes neonatal hemochromatosis, viral hepatitis, and metabolic/genetic and ischemic causes. Structured approach to diagnostic evaluation with multidisciplinary team is needed for early diagnosis and the use of specific therapies. Liver transplantation remains a vital treatment, and prompt referral to a transplant center is crucial.
Literature
1.••
go back to reference Squires RH, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652-658.e2. Seminal study that set the foundation for ALF studies in children.PubMedPubMedCentralCrossRef Squires RH, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652-658.e2. Seminal study that set the foundation for ALF studies in children.PubMedPubMedCentralCrossRef
3.
go back to reference Ng VL, Li R, Loomes KM, Leonis MA, Rudnick DA, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group (PALFSG). Outcomes of children with and without hepatic encephalopathy from the pediatric acute liver failure study group. J Pediatr Gastroenterol Nutr. 2016;63(3):357–64. https://doi.org/10.1097/MPG.0000000000001178. Ng VL, Li R, Loomes KM, Leonis MA, Rudnick DA, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group (PALFSG). Outcomes of children with and without hepatic encephalopathy from the pediatric acute liver failure study group. J Pediatr Gastroenterol Nutr. 2016;63(3):357–64. https://​doi.​org/​10.​1097/​MPG.​0000000000001178​.
4.
go back to reference Pal S, Curley A, Stanworth SJ. Interpretation of clotting tests in the neonate. Arch Dis Child Fetal Neonatal Ed. 2015;100:F270–4.PubMedCrossRef Pal S, Curley A, Stanworth SJ. Interpretation of clotting tests in the neonate. Arch Dis Child Fetal Neonatal Ed. 2015;100:F270–4.PubMedCrossRef
5.
go back to reference Durand P, Debray D, Mandel R, Baujard C, Branchereau S, Gauthier F, Jacquemin E, Devictor D. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr. 2001;139:871–6.PubMedCrossRef Durand P, Debray D, Mandel R, Baujard C, Branchereau S, Gauthier F, Jacquemin E, Devictor D. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr. 2001;139:871–6.PubMedCrossRef
6.
go back to reference Bitar R, Thwaites R, Davison S, Rajwal S, McClean P. Liver failure in early infancy: aetiology, presentation, and outcome. J Pediatr Gastroenterol Nutr. 2017;64:70–5.PubMedCrossRef Bitar R, Thwaites R, Davison S, Rajwal S, McClean P. Liver failure in early infancy: aetiology, presentation, and outcome. J Pediatr Gastroenterol Nutr. 2017;64:70–5.PubMedCrossRef
7.••
go back to reference Borovsky K, Banc-Husu AM, Saul SA, Neighbors K, Kelly S, Alonso EM, Taylor SA. Applying an age-specific definition to better characterize etiologies and outcomes in neonatal acute liver failure. J Pediatr Gastroenterol Nutr. 2021;73:80–5. Most recent descriptive study focused on neonatal liver failure.PubMedCrossRef Borovsky K, Banc-Husu AM, Saul SA, Neighbors K, Kelly S, Alonso EM, Taylor SA. Applying an age-specific definition to better characterize etiologies and outcomes in neonatal acute liver failure. J Pediatr Gastroenterol Nutr. 2021;73:80–5. Most recent descriptive study focused on neonatal liver failure.PubMedCrossRef
8.
go back to reference Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH. Characterization and outcomes of young infants with acute liver failure. J Pediatr. 2011;159:813-818.e1.PubMedPubMedCentralCrossRef Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH. Characterization and outcomes of young infants with acute liver failure. J Pediatr. 2011;159:813-818.e1.PubMedPubMedCentralCrossRef
9.•
go back to reference Feldman AG, Whitington PF. Neonatal hemochromatosis J Clin Exp Hepatol. 2013;3:313–20. Elegant review on neonatal hemochromatosis.PubMedCrossRef Feldman AG, Whitington PF. Neonatal hemochromatosis J Clin Exp Hepatol. 2013;3:313–20. Elegant review on neonatal hemochromatosis.PubMedCrossRef
10.••
go back to reference Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology. 2010;51:2061–8. Seminal paper that changed the paradigm on neonatal hemochromatosis.PubMedCrossRef Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology. 2010;51:2061–8. Seminal paper that changed the paradigm on neonatal hemochromatosis.PubMedCrossRef
11.
go back to reference Debray FG, De Halleux V, Guidi O, Detrembleur N, Gaillez S, Rausin L, Goyens P, Pan X, Whitington PF. Neonatal liver cirrhosis without iron overload caused by gestational alloimmune liver disease. Pediatrics. 2012;129:e1076–9.PubMedCrossRef Debray FG, De Halleux V, Guidi O, Detrembleur N, Gaillez S, Rausin L, Goyens P, Pan X, Whitington PF. Neonatal liver cirrhosis without iron overload caused by gestational alloimmune liver disease. Pediatrics. 2012;129:e1076–9.PubMedCrossRef
12.
go back to reference Jimenez-Rivera C, Gupta A, Feberova J, de Nanassy JA, Boland MP. Successful treatment of neonatal hemochromatosis as gestational alloimmune liver disease with intravenous immunoglobulin. J Neonatal Perinatal Med. 2014;7:301–4.PubMedCrossRef Jimenez-Rivera C, Gupta A, Feberova J, de Nanassy JA, Boland MP. Successful treatment of neonatal hemochromatosis as gestational alloimmune liver disease with intravenous immunoglobulin. J Neonatal Perinatal Med. 2014;7:301–4.PubMedCrossRef
13.
go back to reference Sheflin-Findling S, Annunziato RA, Chu J, Arvelakis A, Mahon D, Arnon R. Liver transplantation for neonatal hemochromatosis: analysis of the UNOS database. Pediatr Transplant. 2015;19:164–9.PubMedCrossRef Sheflin-Findling S, Annunziato RA, Chu J, Arvelakis A, Mahon D, Arnon R. Liver transplantation for neonatal hemochromatosis: analysis of the UNOS database. Pediatr Transplant. 2015;19:164–9.PubMedCrossRef
14.
go back to reference Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics. 2008;121:e1615–21.PubMedCrossRef Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics. 2008;121:e1615–21.PubMedCrossRef
15.
go back to reference Sundaram SS, Alonso EM, Anand R. Outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr. 2008;47:486–92.PubMedCrossRef Sundaram SS, Alonso EM, Anand R. Outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr. 2008;47:486–92.PubMedCrossRef
16.•
go back to reference Jain AK, Anand R, Lerret S, Yanni G, Chen JY, Mohammad S, Doyle M, Telega G, Horslen S. Outcomes following liver transplantation in young infants: data from the SPLIT registry. Am J Transplant. 2021;21:1113–27. Comprehensive data review on outcomes in this unique population.PubMedCrossRef Jain AK, Anand R, Lerret S, Yanni G, Chen JY, Mohammad S, Doyle M, Telega G, Horslen S. Outcomes following liver transplantation in young infants: data from the SPLIT registry. Am J Transplant. 2021;21:1113–27. Comprehensive data review on outcomes in this unique population.PubMedCrossRef
17.
go back to reference Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D. Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021;21:1–12.CrossRef Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D. Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021;21:1–12.CrossRef
18.
go back to reference Sandoni M, Ciardo L, Tamburini C, Boncompagni A, Rossi C, Guidotti I, Garetti E, Lugli L, Iughetti L, Berardi A. Enteroviral infections in the first three months of life. Pathogens. 2022;11:1–14.CrossRef Sandoni M, Ciardo L, Tamburini C, Boncompagni A, Rossi C, Guidotti I, Garetti E, Lugli L, Iughetti L, Berardi A. Enteroviral infections in the first three months of life. Pathogens. 2022;11:1–14.CrossRef
19.
go back to reference Ronchi A, Doern C, Brock E, Pugni L, Sánchez PJ. Neonatal adenoviral infection: a seventeen year experience and review of the literature. J Pediatr. 2014;164(529–35):e1-4. Ronchi A, Doern C, Brock E, Pugni L, Sánchez PJ. Neonatal adenoviral infection: a seventeen year experience and review of the literature. J Pediatr. 2014;164(529–35):e1-4.
20.
go back to reference Gutierrez Sanchez LH, Shiau H, Baker JM, et al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med. 2022;387:620–30.PubMedCrossRef Gutierrez Sanchez LH, Shiau H, Baker JM, et al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med. 2022;387:620–30.PubMedCrossRef
21.
go back to reference Ho A, Orton R, Tayler R, et al. Adeno-associated virus 2 infection in children with non-A–E hepatitis. Nature. 2023;617:555–63.PubMedCrossRef Ho A, Orton R, Tayler R, et al. Adeno-associated virus 2 infection in children with non-A–E hepatitis. Nature. 2023;617:555–63.PubMedCrossRef
22.
go back to reference Molleston JP, Sokol RJ, Karnsakul W, Miethke A, Horslen S, Magee JC, Romero R, Squires RH, Van Hove JLK. Evaluation of the child with suspected mitochondrial liver disease. J Pediatr Gastroenterol Nutr. 2013;57:269–76.PubMedPubMedCentralCrossRef Molleston JP, Sokol RJ, Karnsakul W, Miethke A, Horslen S, Magee JC, Romero R, Squires RH, Van Hove JLK. Evaluation of the child with suspected mitochondrial liver disease. J Pediatr Gastroenterol Nutr. 2013;57:269–76.PubMedPubMedCentralCrossRef
24.
go back to reference Fellman V, Kotarsky H. Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med. 2011;16:222–8.PubMedCrossRef Fellman V, Kotarsky H. Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med. 2011;16:222–8.PubMedCrossRef
25.•
go back to reference Ayers M, Horslen SP, Gómez AM, Squires JE. Mitochondrial hepatopathy. Clin Liver Dis. 2023;26:421–38. Excellent review with recent advances and expert guidance on evaluation.CrossRef Ayers M, Horslen SP, Gómez AM, Squires JE. Mitochondrial hepatopathy. Clin Liver Dis. 2023;26:421–38. Excellent review with recent advances and expert guidance on evaluation.CrossRef
26.
go back to reference García-Cazorla A, De Lonlay P, Nassogne MC, Rustin P, Touati G, Saudubray JM. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics. 2005;116:1170–7.PubMedCrossRef García-Cazorla A, De Lonlay P, Nassogne MC, Rustin P, Touati G, Saudubray JM. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics. 2005;116:1170–7.PubMedCrossRef
28.
go back to reference Dubern B, Broue P, Dubuisson C, Cormier-Daire V, Habes D, Chardot C, Devictor D, Munnich A, Bernard O. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation. 2001;71:633–7.PubMedCrossRef Dubern B, Broue P, Dubuisson C, Cormier-Daire V, Habes D, Chardot C, Devictor D, Munnich A, Bernard O. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation. 2001;71:633–7.PubMedCrossRef
29.
go back to reference Hostetter MK, Levy HL, Winter HS, Knight GJ, Haddow JE. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med. 1983;308:1265–7.PubMedCrossRef Hostetter MK, Levy HL, Winter HS, Knight GJ, Haddow JE. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med. 1983;308:1265–7.PubMedCrossRef
30.
go back to reference Bartlett DC, Lloyd C, McKiernan PJ, Newsome PN. Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function. J Inherit Metab Dis. 2014;37:745–52.PubMedCrossRef Bartlett DC, Lloyd C, McKiernan PJ, Newsome PN. Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function. J Inherit Metab Dis. 2014;37:745–52.PubMedCrossRef
31.
go back to reference Van GWG, Rodenburg IL, Harding CO, Hollak CEM, Heiner MR, Van SFJ. Long - term outcomes and practical considerations in the pharmacological management of tyrosinemia type 1. Pediatr Drugs. 2019;21:413–26.CrossRef Van GWG, Rodenburg IL, Harding CO, Hollak CEM, Heiner MR, Van SFJ. Long - term outcomes and practical considerations in the pharmacological management of tyrosinemia type 1. Pediatr Drugs. 2019;21:413–26.CrossRef
33.
go back to reference Hegarty R, Hadzic N, Gissen P, Dhawan A. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King’s College Hospital experience. Eur J Pediatr. 2015;174:1387–92.PubMedCrossRef Hegarty R, Hadzic N, Gissen P, Dhawan A. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King’s College Hospital experience. Eur J Pediatr. 2015;174:1387–92.PubMedCrossRef
34.
go back to reference Porta F, Pagliardini S, Pagliardini V, Ponzone A, Spada M. Newborn screening for galactosemia: a 30-year single center experience. World J Pediatr. 2015;11:160–4.PubMedCrossRef Porta F, Pagliardini S, Pagliardini V, Ponzone A, Spada M. Newborn screening for galactosemia: a 30-year single center experience. World J Pediatr. 2015;11:160–4.PubMedCrossRef
35.
go back to reference Walter JH, Collins JE, Leonard JV. Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child. 1999;80:93–6.PubMedPubMedCentralCrossRef Walter JH, Collins JE, Leonard JV. Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child. 1999;80:93–6.PubMedPubMedCentralCrossRef
36.
go back to reference Verhoeven NM, Wallot M, Huck JHJ, Dirsch O, Ballauf A, Neudorf U, Salomons GS, van der Knaap MS, Voit T, Jakobs C. A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis. 2005;28:169–79.PubMedCrossRef Verhoeven NM, Wallot M, Huck JHJ, Dirsch O, Ballauf A, Neudorf U, Salomons GS, van der Knaap MS, Voit T, Jakobs C. A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis. 2005;28:169–79.PubMedCrossRef
37.
go back to reference Balasubramaniam S, Wamelink MM, Ngu LH, Talib A, Salomons GS, Jakobs C, Keng WT. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr. 2011;52:113–6.PubMedCrossRef Balasubramaniam S, Wamelink MM, Ngu LH, Talib A, Salomons GS, Jakobs C, Keng WT. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr. 2011;52:113–6.PubMedCrossRef
38.
go back to reference Shneider BL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr. 1994;124:234–8.PubMedCrossRef Shneider BL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr. 1994;124:234–8.PubMedCrossRef
39.••
go back to reference Taylor SA, Whitington PF. Neonatal acute liver failure. Liver Transplant. 2016;22:677–85. Excellent review on the etiopathogenesis.CrossRef Taylor SA, Whitington PF. Neonatal acute liver failure. Liver Transplant. 2016;22:677–85. Excellent review on the etiopathogenesis.CrossRef
41.•
go back to reference Hadžić N, Molnar E, Height S, Kovács G, Dhawan A, Andrikovics H, Worth A, Gilmour KC. High prevalence of hemophagocytic lymphohistiocytosis in acute liver failure of infancy. J Pediatr. 2022;250:67-74.e1. Study highlights new data on etiology.PubMedCrossRef Hadžić N, Molnar E, Height S, Kovács G, Dhawan A, Andrikovics H, Worth A, Gilmour KC. High prevalence of hemophagocytic lymphohistiocytosis in acute liver failure of infancy. J Pediatr. 2022;250:67-74.e1. Study highlights new data on etiology.PubMedCrossRef
42.
go back to reference Amir AZ, Ling SC, Naqvi A, et al. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis. Liver Transplant. 2016;22:1245–53.CrossRef Amir AZ, Ling SC, Naqvi A, et al. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis. Liver Transplant. 2016;22:1245–53.CrossRef
43.
go back to reference Matthes-Martin S, Peters C, Königsrainer A, et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood. 2000;96:3997–9.PubMedCrossRef Matthes-Martin S, Peters C, Königsrainer A, et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood. 2000;96:3997–9.PubMedCrossRef
45.
go back to reference Choudhary M, Sharma D, Dabi D, Lamba M, Pandita A, Shastri S. Hepatic dysfunction in asphyxiated neonates: prospective case-controlled study. Clin Med Insights Pediatr. 2015;9:CMPed.S21426.CrossRef Choudhary M, Sharma D, Dabi D, Lamba M, Pandita A, Shastri S. Hepatic dysfunction in asphyxiated neonates: prospective case-controlled study. Clin Med Insights Pediatr. 2015;9:CMPed.S21426.CrossRef
46.
go back to reference Zozaya Nieto C, FernándezCaamaño B, Muñoz Bartolo G, Menéndez Suso JJ, FraucaRemacha E, ValverdeNúñez E. Presenting features and prognosis of ischemic and nonischemic neonatal liver failure. J Pediatr Gastroenterol Nutr. 2017;64:754–9.PubMedCrossRef Zozaya Nieto C, FernándezCaamaño B, Muñoz Bartolo G, Menéndez Suso JJ, FraucaRemacha E, ValverdeNúñez E. Presenting features and prognosis of ischemic and nonischemic neonatal liver failure. J Pediatr Gastroenterol Nutr. 2017;64:754–9.PubMedCrossRef
47.
go back to reference Iacobas I, Phung TL, Adams DM, Trenor CC, Blei F, Fishman DS, Hammill A, Masand PM, Fishman SJ. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr. 2018;203:294-300.e2.PubMedCrossRef Iacobas I, Phung TL, Adams DM, Trenor CC, Blei F, Fishman DS, Hammill A, Masand PM, Fishman SJ. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr. 2018;203:294-300.e2.PubMedCrossRef
48.•
go back to reference Aziz H, Brown ZJ, Baghdadi A, Kamel IR, Pawlik TM. A comprehensive review of hepatic hemangioma management. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2022;26:1998–2007. Excellent review on the topic.CrossRef Aziz H, Brown ZJ, Baghdadi A, Kamel IR, Pawlik TM. A comprehensive review of hepatic hemangioma management. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2022;26:1998–2007. Excellent review on the topic.CrossRef
49.
go back to reference Cheung M, Bansal S, Aw MM, Buchanan CR, Mieli-Vergani G, Dhawan A. Liver failure in a neonate with congenital adrenal hyporesponsiveness. Eur J Pediatr. 2003;162:558.PubMedCrossRef Cheung M, Bansal S, Aw MM, Buchanan CR, Mieli-Vergani G, Dhawan A. Liver failure in a neonate with congenital adrenal hyporesponsiveness. Eur J Pediatr. 2003;162:558.PubMedCrossRef
50.
go back to reference Spray CH, Mckiernan P, Waldron KE, Shaw N, Kirk J, Kelly DA. Investigation and outcome of neonatal hepatitis in infants with hypopituitarism. Acta Paediatr. 2000;89:951–4.PubMedCrossRef Spray CH, Mckiernan P, Waldron KE, Shaw N, Kirk J, Kelly DA. Investigation and outcome of neonatal hepatitis in infants with hypopituitarism. Acta Paediatr. 2000;89:951–4.PubMedCrossRef
51.
go back to reference Haack TB, Staufner C, Köpke MG, et al. Biallelic mutations in NBAS cause recurrent acute liver failure with onset in infancy. Am J Hum Genet. 2015;97:163–9.PubMedPubMedCentralCrossRef Haack TB, Staufner C, Köpke MG, et al. Biallelic mutations in NBAS cause recurrent acute liver failure with onset in infancy. Am J Hum Genet. 2015;97:163–9.PubMedPubMedCentralCrossRef
52.
go back to reference Cousin MA, Conboy E, Wang J-S, et al. RINT1 Bi-allelic variations cause infantile-onset recurrent acute liver failure and skeletal abnormalities. Am J Hum Genet. 2019;105:108–21.PubMedPubMedCentralCrossRef Cousin MA, Conboy E, Wang J-S, et al. RINT1 Bi-allelic variations cause infantile-onset recurrent acute liver failure and skeletal abnormalities. Am J Hum Genet. 2019;105:108–21.PubMedPubMedCentralCrossRef
53.
go back to reference Casey JP, Slattery S, Cotter M, et al. Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. J Inherit Metab Dis. 2015;38:1085–92.PubMedCrossRef Casey JP, Slattery S, Cotter M, et al. Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. J Inherit Metab Dis. 2015;38:1085–92.PubMedCrossRef
55.•
go back to reference Thompson WS, Greenmyer JR, Lanpher BC, Brumbaugh JE, Bendel-Stenzel EM, Dimmock DP, Hobbs CA, Ibrahim SH, Hildreth AN. Ultra-rapid whole genome sequencing: a paradigm shift in the pre-transplant evaluation of neonatal acute liver failure. Liver Transplant. 2023;29:118–21. Case series highlighting recent advances with potentially significant impact on outcomes.CrossRef Thompson WS, Greenmyer JR, Lanpher BC, Brumbaugh JE, Bendel-Stenzel EM, Dimmock DP, Hobbs CA, Ibrahim SH, Hildreth AN. Ultra-rapid whole genome sequencing: a paradigm shift in the pre-transplant evaluation of neonatal acute liver failure. Liver Transplant. 2023;29:118–21. Case series highlighting recent advances with potentially significant impact on outcomes.CrossRef
56.
go back to reference Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med. 2012;33:80–95.PubMedCrossRef Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med. 2012;33:80–95.PubMedCrossRef
57.
go back to reference Seki S, Habu Y, Kawamura T, Takeda K, Dobashi H, Ohkawa T, Hiraide H. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev. 2000;174:35–46.PubMedCrossRef Seki S, Habu Y, Kawamura T, Takeda K, Dobashi H, Ohkawa T, Hiraide H. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev. 2000;174:35–46.PubMedCrossRef
58.
go back to reference Godbole G, Shanmugam N, Dhawan A, Verma A. Infectious complications in pediatric acute liver failure. J Pediatr Gastroenterol Nutr. 2011;53:320–5.PubMedCrossRef Godbole G, Shanmugam N, Dhawan A, Verma A. Infectious complications in pediatric acute liver failure. J Pediatr Gastroenterol Nutr. 2011;53:320–5.PubMedCrossRef
59.
60.
go back to reference Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transplant. 2003;9:783–8.CrossRef Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transplant. 2003;9:783–8.CrossRef
61.
go back to reference Sundaram SS, Alonso EM, Anand R, Study of pediatric liver transplantation research group. outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr. 2008;47:486–92.PubMedCrossRef Sundaram SS, Alonso EM, Anand R, Study of pediatric liver transplantation research group. outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr. 2008;47:486–92.PubMedCrossRef
62.
go back to reference Gelas T, McKiernan PJ, Kelly DA, Mayer DA, Mirza DF, Sharif K. ABO-incompatible pediatric liver transplantation in very small recipients: Birmingham’s experience. Pediatr Transplant. 2011;15:706–11.PubMedCrossRef Gelas T, McKiernan PJ, Kelly DA, Mayer DA, Mirza DF, Sharif K. ABO-incompatible pediatric liver transplantation in very small recipients: Birmingham’s experience. Pediatr Transplant. 2011;15:706–11.PubMedCrossRef
Metadata
Title
Acute Liver Failure in Neonates and Early Infancy: an Approach to Diagnosis and Management
Authors
Sanu Raja Yadav
Praveen Kumar Conjeevaram Selvakumar
Kadakkal Radhakrishnan
Publication date
01-12-2023
Publisher
Springer US
Published in
Current Pediatrics Reports / Issue 4/2023
Electronic ISSN: 2167-4841
DOI
https://doi.org/10.1007/s40124-023-00301-7

Other articles of this Issue 4/2023

Current Pediatrics Reports 4/2023 Go to the issue